[Retracted] Activating IL-6/STAT3 Enhances Protein Stability of Proteasome 20S α+β in Colorectal Cancer by miR-1254

Table 2

Correlation between proteasome 20S α+β expression and clinicopathologic characteristics in 90 CRC patients.

Variables	Proteasome 20S α+β expression
	Total	Low	High	value
Gender				0.432
Male	42	32 (76.2%)	10 (23.8%)
Female	48	33 (68.8%)	15 (31.2%)
Age (years)				0.595
≤60	29	22 (75.9%)	7 (24.1%)
>60	61	43 (70.5%)	18 (29.5%)
Size				0.001
≤5 cm	43	38 (88.4%)	5 (11.6%)
>5 cm	47	27 (57.4%)	20 (42.6%)
Depth of invasion				0.457
≤pT2	13	11 (84.6%)	2 (15.4%)
≥pT3	77	54 (70.1%)	23 (29.9%)
Lymph node metastasis				0.002
No	59	49 (83.1%)	10 (16.9%)
Yes	31	16 (51.6%)	15 (48.4%)
Distant metastasis				0.030
No metastasis	85	64 (75.3%)	21 (24.7%)
Metastasis	5	1 (20.0%)	4 (80.0%)
Localization				0.367
Proximal colon	14	12 (85.7%)	2 (14.3%)
Distal colon	76	53 (69.7%)	23 (30.3%)
TNM stage				≤0.01
I and II	57	49 (86.0%)	8 (14.0%)
III and IV	33	16 (48.5%)	17 (51.5%)
Histological grade				0.140
Well	6	5 (83.3%)	1 (16.7%)
Moderately	70	53 (75.7%)	17 (24.3%)
Poorly	14	7 (50.0%)	7 (50.0%)
CEA (μg/L)				≤0.01
≥5	54	47 (87.0%)	7 (13.0%)
<5	36	18 (72.2%)	18 (27.8%)
pSTAT3				≤0.01
Low	57	51 (89.47%)	6 (10.53%)
High	33	14 (42.42%)	19 (57.58%)

, , and .